Competitive Technologies Establishes Relationship with Medical College of Georgia Research Institute to Commercialize Innovative Green Tea Formulation.

FAIRFIELD, Conn. -- Green Tea Anti-Dandruff Shampoo Offers Natural and Effective Alternative to Chemical Shampoos

Competitive Technologies, Inc. (AMEX: CTT) today announced that it has signed an exclusive, worldwide service and representation agreement with the Medical College of Georgia Research Institute to commercialize cleansers and related skin care products which are formulated with green tea extract.

Green tea contains naturally occurring compounds called Green Tea Polyphenols (GTP) which have anti-oxidant, anti-cancer, anti-microbial and anti-inflammation properties. Cleansers utilizing this novel formulation are better able to permeate the skin, maximizing these beneficial aspects of the product and thereby improving skin conditions. This method provides a 100% natural, non-chemical alternative to existing products and can be added to a wide variety of cleansers. For example, shampoos formulated utilizing this method have shown remarkable effects against dandruff. In addition, GTPs can be used in shaving creams, facial cleansers, beauty bars, hand soaps and dish soaps. Even pet shampoos can be formulated with GTPs, allowing increased frequency of bathing without skin irritation and improving pets' skin condition. This patent-pending formulation is lipid-based and offers advantages over existing water-based formulations which are unstable and do not permeate the skin as well.

"We are confident that these natural GTP formulations have broad commercial potential in the cosmetic and consumer detergent markets," remarked Kevin Drumm, Business Development Executive for Competitive Technologies, Inc. "We are excited about working with the Medical College of Georgia Research Institute to bring this novel technology to market."

"As we continue to build CTT's technology pipeline, this is a strong addition to our portfolio of IP assets. With numerous cosmetic applications, we are excited about the prospects for the green tea technology and establishing a fruitful, long-term relationship with the Medical College of Georgia Research Institute," stated Mike Kiley, Ph.D., Executive Vice President and Chief Operating Officer of Competitive Technologies.

About Medical College of Georgia

The Medical College of Georgia, the state's premier academic health sciences university, has much to offer the corporate sector. With a rapidly expanding research program (with special emphasis in cardiovascular disease, neurological disease, cancer, infection & inflammation, and diabetes & obesity), it offers numerous opportunities for licensing and for conducting joint research projects. The MCG Office of Technology Transfer & Economic Development, which orchestrated the license with Competitive Technologies, is a main point of entry for corporations wishing to work with the medical program based in Augusta. The Medical College of Georgia is involved in nearly 400 different funded research activities and related studies in its Schools of Allied Health Sciences. Dentistry, Graduate Studies, Medicine and Nursing. Research is carried out both in basic and clinical disciplines. For more information, please visit http://www.mcg.edu/research/techtransfer.

About Competitive Technologies, Inc.

Competitive Technologies, established in 1968, is a full service technology transfer and licensing provider, focused on bringing the intellectual property assets of its clients to the marketplace. CTT specializes in identifying, developing and commercializing innovative technologies in a variety of areas, including life and physical sciences, electronics, and nanotechnologies. Through its global distribution platform, CTT maximizes the value of its clients' intellectual property assets. For more information, please visit: www.competitivetech.net.

Statements about our future expectations, including development and regulatory plans, and all other statements in this press release, other than historical facts, are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. If and when used herein, the words "may," "will," "should," "anticipate," "believe," "intend," "plan," "expect," "estimate," "approximate," and similar expressions, as they relate to us or our business or management, are intended to identify such forward-looking statements. These statements involve risks and uncertainties related to our ability to obtain rights to market technologies, market acceptance of and competition for our licensed technologies, growth strategies and strategic plans, operating performance, industry trends, and other risks and uncertainties inherent in our business, including those set forth in Item 7 under the caption "Risk Factors," in our most recent Annual Report on Form 10-K for the year ended July 31, 2005, filed with the Securities and Exchange Commission ("SEC") on October 13, 2005, and other factors that may be described in our other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.